Skip to Main Content

Paper Details

Topical therapy for regression and melanoma prevention of congenital giant nevi.
Cell
11
2022
Giant, Giant congenital melanocytic nevi, MEK, NRAS, PI3K, SADBE, c-KIT, children, congenital giant nevi, giant, giant congenital nevi, giant nevus, human, melanoma, mice, nevi, nevocytes, nevus, squaric acid dibutylester, xenografted human
Author NameAffiliation
Norman E SharplessNational Cancer Institute, National Institute of Health
Norman E SharplessNational Cancer Institute, National Institute of Health
Xiaole Shirley LiuDana Farber Cancer Institute, Harvard T.H. Chan School of Public Health
Clifford A MeyerDana Farber Cancer Institute, Harvard T.H. Chan School of Public Health
Dave S B HoonSaint John's Cancer Institute Providence Health and System
Dave S B HoonSaint John's Cancer Institute Providence Health and System
Shadmehr DemehriCutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School
David E FisherCutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School
David E FisherCutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School
  • 1 - 9

Datasets

Release 1.2